XML 21 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 29, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Information Related to Stock-Based Compensation Plans
The following table sets forth certain information regarding the 1995 Plan:
 
March 29,
2015
Shares available for grant
1,909,185

Shares of common stock reserved for issuance pursuant to outstanding exercisable securities
3,236,286

Schedule of Options Outstanding and Exercisable
The following table sets forth certain information regarding all options outstanding and exercisable:
 
March 29, 2015
 
Options
Outstanding
 
Options
Exercisable
Number
779,158

 
299,095

Weighted average exercise price
$
62.38

 
$
45.79

Aggregate intrinsic value
$ 13.4 million

 
$ 9.4 million

Weighted average remaining contractual term
4.7 years

 
3.5 years

Schedule of Restricted Stock Units Nonvested and Expected to Vest
The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
 
March 29, 2015
 
RSUs Nonvested
 
RSUs Expected
to Vest
Number
547,945

 
488,536

Weighted average grant date per share fair value
$
70.86

 
$
70.25

Aggregate intrinsic value
$ 41.3 million

 
$ 36.9 million

Weighted average remaining term to vest
1.3 years

 
1.3 years

Schedule of Stock-Based Compensation Expense
Our stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):
 
Thirteen Weeks Ended
 
March 29,
2015
 
March 30,
2014
Cost of sales
$
792

 
$
726

Research and development
630

 
617

Selling, general and administrative
4,527

 
3,796

Total stock-based compensation
$
5,949

 
$
5,139